Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark

This study highlights poor outcomes for patients with BPDCN in the modern era and the need for new treatments. Outcomes from ongoing clinical trials for BPDCN can be evaluated relative to this contemporary cohort.

Source: Blood - August 21, 2019 Category: Hematology Authors: Taylor, J., Haddadin, M., Upadhyay, V. A., Grussie, E., Mehta-Shah, N., Brunner, A. M., Louissaint, A., Lovitch, S. B., Dogan, A., Fathi, A. T., Stone, R. M., Tallman, M. S., Rampal, R. K., Neuberg, D. S., Stevenson, K. E., Horwitz, S. M., Lane, A. A. Tags: Lymphoid Neoplasia, Clinical Trials and Observations Source Type: research